​

Eton Pharmaceuticals Ownership | Who Owns Eton Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Eton Pharmaceuticals Ownership Summary


Eton Pharmaceuticals is owned by 72.83% institutional investors, 5.17% insiders, and 21.99% retail investors. Opaleye management is the largest institutional shareholder, holding 10.48% of ETON shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 3.04% of its assets in Eton Pharmaceuticals shares.

ETON Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEton Pharmaceuticals72.83%5.17%21.99%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustrySpecialty & Generic Drug Manufacturers Stocks37.69%14.20%48.11%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Opaleye management2.86M10.48%$103.53M
Ecor1 capital2.17M7.96%$78.62M
Blackrock funding, inc. /de2.10M7.58%$107.92M
Vanguard group1.35M5.01%$22.81M
Vanguard capital management1.20M4.35%$61.96M
Nantahala capital management875.51K3.17%$45.08M
Fmr823.59K2.98%$42.41M
State street775.54K2.81%$39.93M
Geode capital management764.40K2.77%$39.37M
Morgan stanley513.17K1.86%$26.42M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Opaleye management2.86M9.38%$103.53M
Pillsbury lake capital288.27K5.67%$14.84M
Cannell capital341.99K5.18%$8.44M
Ecor1 capital2.17M3.82%$78.62M
Panoramic capital208.19K3.24%$7.54M
Westside investment management401.38K2.63%$20.67M
Prospect capital advisors157.20K2.58%$5.69M
Lumbard & kellner173.26K2.53%$8.92M
Nantahala capital management875.51K1.43%$45.08M
Guilbault capital21.02K1.06%$1.08M

Top Buyers

HolderShares% AssetsChange
Fmr823.59K0.00%821.46K
Vanguard capital management1.20M0.00%226.77K
Rockefeller capital management223.70K0.02%223.70K
Marshall wace, llp457.43K0.02%208.25K
Blackrock funding, inc. /de2.10M0.00%200.08K

Top Sellers

HolderShares% AssetsChange
Bnp paribas arbitrage, snc19.06K0.00%-303.41K
Nantahala capital management875.51K1.43%-300.44K
Parkman healthcare partners---276.89K
Morgan stanley513.17K0.00%-254.80K
Paradigm capital management inc/ny---200.00K

New Positions

HolderShares% AssetsChangeValue
Rockefeller capital management223.70K0.02%223.70K$11.52M
Norges bank169.50K0.00%169.50K$6.14M
Prospect capital advisors157.20K2.58%157.20K$5.69M
Qube research155.65K0.01%155.65K$8.01M
Rpg family wealth advisory85.27K0.78%85.27K$4.39M

Sold Out

HolderChange
National bank of canada /fi/-4.00
Lindbrook capital-4.00
Investors portfolio services-34.00
Twin peaks wealth advisors-38.00
Advisory services network-50.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202617040.50%19,872,62811.74%721.71%11681.25%32-3.03%
Mar 31, 202652-50.00%3,591,014-77.40%130.38%27-43.75%15-59.46%
Dec 31, 202562-40.38%8,912,362-49.64%330.77%30-45.45%22-18.52%
Sep 30, 20259818.07%17,454,5999.66%641.85%51-12.07%2758.82%
Jun 30, 202586-1.15%16,537,10735.73%612.99%6115.09%17-26.09%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard MStar Total Stk Mkt Idx Invest869.38K3.04%172.40K
Vanguard US Total Market Shares ETF681.72K2.54%-
Vanguard Total Stock Mkt Idx Inv684.82K2.50%30.10K
Vanguard Morn Total Stk Mkt Idx Investor684.82K2.50%30.10K
iShares Russell 2000 ETF672.34K2.33%-
Oberweis Micro-Cap Growth483.90K1.77%63.00K
Oberweis Micro-Cap483.90K1.69%63.00K
Fidelity Small Cap Growth439.15K1.52%186.19K
Fidelity Small Cap Index292.34K1.01%444.00
Vanguard Institutional Extnd Mkt Idx Tr271.49K0.96%486.00

Recent Insider Transactions


DateNameRoleActivityValue
Nov 10, 2026Erdogan-Trinkaus Ipek Chief Commercial OfficerSell$78.74K
Nov 10, 2026Erdogan-Trinkaus Ipek Chief Commercial OfficerSell$157.20K
Nov 10, 2026CASAMENTO CHARLES J-Sell$1.50M
Nov 10, 2026CASAMENTO CHARLES J-Sell$410.42K
Nov 10, 2026CASAMENTO CHARLES J-Sell$961.26K

Insider Transactions Trends


DateBuySell
2026 Q4-8
2026 Q3-15
2026 Q2-8
2026 Q1--
2025 Q4--

ETON Ownership FAQ


Who Owns Eton Pharmaceuticals?

Eton Pharmaceuticals shareholders are primarily institutional investors at 72.83%, followed by 5.17% insiders and 22.00% retail investors. The average institutional ownership in Eton Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 37.69%, which Eton Pharmaceuticals exceeds.

Who owns the most shares of Eton Pharmaceuticals?

Eton Pharmaceuticals’s largest shareholders are Opaleye management (2.86M shares, 10.48%), Ecor1 capital (2.17M shares, 7.96%), and Blackrock funding, inc. /de (2.1M shares, 7.58%). Together, they hold 26.02% of Eton Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eton Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eton Pharmaceuticals.

Who is Eton Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Opaleye management is Eton Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 9.38% of its assets in 2.86M Eton Pharmaceuticals shares, valued at 103.53M$.

Who is the top mutual fund holder of Eton Pharmaceuticals shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of Eton Pharmaceuticals shares, with 3.04% of its total shares outstanding invested in 869.38K Eton Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools